Yep LCYB “acquired” the plant and land, the IP, the patents, trade names, trademarks and everything else of value listed on about 100 pages of the APA as well as very well defined in that APA.
LCYB did not “acquire” the shares or the corporation though so shareholders lost their investment.
That “upfront” payment of $334,000 with the LOI and balance paid at closing is going to be a hard lesson learned for some unfortunately!!
It’s too bad the shares and shell were never “acquired”
It’s 2022 and the shares are still worthless. If BioAmber as a whole was acquired in 2019 the shareholders would have been informed of the sale but as we all know that never happened
The shareholders were however informed that equity investors of the company had ZERO value coming from the liquidation of the assets.
I guess that letter from LCY’s lawyer was spot on when they said they were not paying anything else lol
TRY HARDER LOL!!!
News 
Market Data 
Discover 
AI
